Down 25% YTD, Should Investors Scoop Up Shares of COMPASS Pathways?

Healthcare companies are continuously looking for new treatment options for patients. One in particular, COMPASS Pathways (CMPS), is focused on using psilocybin therapy treat depression. The stock has generated a lot of interest, but is down 25% for th…

Paccar vs. Oshkosh: Which Truck Manufacturing Stock is a Better Buy?

The rising demand for raw materials has led to a substantial increase in the demand for cargo trucks over the past couple of months. As manufacturing and industrial production continues to rise, we think truck manufacturers Paccar (PCAR) and Oshkosh (O…

4 Top-Rated Digital Marketing Stocks to Own in 2021

With rising demand for online marketplaces, companies have been increasing their digital footprints. The trend is also driving an increased focus on digital marketing. As a result, we think Adobe (ADBE), América Móvil (AMX), Interpublic Group (IPG), an…

Is Fisker a Buy After Announcing a Deal with Foxconn?

Electric Vehicle (EV) maker Fisker (FSR) has been making headlines after inking a major deal with Chinese EV manufacturing company Foxconn. However, because production of its EV model (Project PEAR) is not expected to begin until the fourth quarter of …